Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million

"For years, our colleagues have proudly manufactured, sold and distributed RSDL® to many branches of the U.S. government to ensure military personnel safety and public health preparedness," said Joe Papa, president and chief executive officer at Emergent. "SERB is a well-positioned global leader that is expected to continue to make RSDL® readily available for the U.S. and allied governments." RSDL®is anFDA-cleared device provided as kit consisting of a lotion impregnated sponge in a packet, it is intended t ...